PubMed=20562528; DOI=10.4161/mabs.12350; PMCID=PMC3180087
Olivier S., Jacoby M., Brillon C., Bouletreau S., Mollet T., Nerriere O., Angel A., Danet S., Souttou B., Guehenneux F., Gauthier L., Berthome M., Vie H., Beltraminelli N., Mehtali M.
EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity.
MAbs 2:405-415(2010)

PubMed=21502045
Brown S.W., Mehtali M.
The avian EB66(R) cell line, application to vaccines, and therapeutic protein production.
PDA J. Pharm. Sci. Technol. 64:419-425(2010)

PubMed=25903999; DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)

PubMed=26409141; DOI=10.1016/j.vaccine.2015.09.022
Naruse T., Fukuda T., Tanabe T., Ichikawa M., Oda Y., Tochihara S., Kimachi K., Kino Y., Ueda K.
A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.
Vaccine 33:6078-6084(2015)

Patent=US9260694
Guehenneux F., Moreau K., Esnault M., Mehtali M.
Generation of duck cell lines.
Patent number US9260694, 16-Feb-2016